key: cord-031534-agj3nnr8
authors: Calderón, José Lemus; Martin, Pedro Beneyto; Rodriguez, Raúl Guzmán; Cataldi, Horacio Caligaris; Sánchez, Carlos Senent
title: Differentiating characteristics of asthmatic patients in the SARS-CoV2 infection.
date: 2020-09-07
journal: Ann Allergy Asthma Immunol
DOI: 10.1016/j.anai.2020.09.004
sha: 
doc_id: 31534
cord_uid: agj3nnr8

nan

(1), surpassed twenty-one million infections and more than seven hundred thousand 3 deaths globally (2), numbers that continue to rise. The prognosis of SARS-CoV-2 4 infection worsens when comorbidities such as high blood pressure, chronic obstructive 5 pulmonary disease, diabetes mellitus, cardiovascular disease, and obesity are associated 6 (3, 4) . There are communications that suggest that asthma may be a factor that 7 determines the severity of the COVID 19, compared to others that indicate that it does 8 not imply an increased risk (5) . The prevalence of asthma in Spain is estimated at 6.3% 9 of the population (6), and in a cohort of hospitalized patients in Spain with SARS-CoV-10 2 infection was 8.4% (7) . The main objective of our study was analyze how the SARS-

CoV-2 infection has affected asthmatic patients in terms of prevalence, morbidity, 12 hospitalization and mortality. 

Coronavirus Disease (COVID-19) Situation Reports

Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19

Risk factors for severity and mortality in adult COVID-19 in patients in Wuhan

Is asthma a risk factor for severe outcomes?

Guía Española para el Manejo del Asma (GEMA) Versión 5.0. Año 2020

Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network. Infectious Diseases (except HIV/AIDS)

Re-using Electronic Health Records with Artificial Intelligence

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective